Home Newsfeeds BTIG Initiates Coverage On Embecta with Neutral Rating

BTIG Initiates Coverage On Embecta with Neutral Rating

BTIG analyst Marie Thibault initiates coverage on Embecta (NASDAQ:EMBC) with a Neutral rating.

byBenzinga Newsdesk

September 8, 2022

1 minute read

BTIG analyst Marie Thibault initiates coverage on Embecta (NASDAQ:EMBC) with a Neutral rating.

Why Is Spotify Stock Trading Lower Friday?

By Anusuya Lahiri

December 8, 8:45 AM

Spotify Technology S.A. (NYSE: SPOT) stock is trading lower Friday as the company's CFO Paul Vogel prepared to depart, effective March 31.

SPOT

Tesla Signage Reveals Cybertruck Details: Will It Live Up To Lofty Expectations?

By Benzinga EV Insights

November 20, 3:29 PM

Tesla Inc's (NASDAQ: TSLA) latest advertising efforts are setting high expectations for the upcoming Cybertruck, as seen in a new advertisement at their

TSLA

News

Aptorum Group Updates On The Clinical Validation Of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics

By Benzinga Newsdesk

September 15, 7:07 AM

Aptorum Group Limited (NASDAQ:APM, PARIS:APM) a clinical stage biopharmaceutical company dedicated to tackling unmet medical needs in oncology, autoimmune diseases and infectious diseases, is pleased to announce further

APM

Nordson Corporation Board Of Directors Increases Dividend From $0.65/Share To $0.68/Share

By Benzinga Newsdesk

August 9, 8:37 AM

Nordson Corporation (NASDAQ:NDSN) today announced that its Board of Directors has approved a 5 percent increase in the Company's quarterly cash dividend to $0.68 per common share from $0.65. The dividend is payable on

NDSN

BTIG Initiates Coverage On Embecta with Neutral Rating

Related Posts

Why Is Spotify Stock Trading Lower Friday?

Tesla Signage Reveals Cybertruck Details: Will It Live Up To Lofty Expectations?

Aptorum Group Updates On The Clinical Validation Of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics

Nordson Corporation Board Of Directors Increases Dividend From $0.65/Share To $0.68/Share